ROSENBLUM SILVERMAN SUTTON S F INC /CA - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 132 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2013. The put-call ratio across all filers is 0.04 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROSENBLUM SILVERMAN SUTTON S F INC /CA ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$3,570,000
-3.7%
82,610
-5.9%
1.70%
+14.7%
Q2 2015$3,709,000
+25.8%
87,760
+0.2%
1.48%
+17.0%
Q4 2014$2,948,000
-4.8%
87,560
-1.0%
1.27%
-8.9%
Q3 2014$3,098,000
+5.0%
88,460
-1.5%
1.39%
+1.1%
Q2 2014$2,951,000
-12.5%
89,810
-1.8%
1.38%
-13.8%
Q1 2014$3,371,000
-3.0%
91,460
+1.0%
1.60%
-2.9%
Q4 2013$3,476,000
+39.7%
90,560
-0.3%
1.64%
+23.4%
Q3 2013$2,488,00090,8101.33%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 261,361$8,588,0006.86%
Black Creek Investment Management Inc. 1,644,485$54,038,0005.68%
Consonance Capital Management LP 1,143,315$37,569,0005.59%
Sloane Robinson LLP 120,000$3,943,0002.47%
THOMAS WHITE INTERNATIONAL LTD 470,769$15,469,0002.16%
Grandeur Peak Global Advisors, LLC 295,035$9,695,0002.09%
Mirae Asset Global Investments Co., Ltd. 2,370,406$77,891,0001.73%
Granite Point Capital Management, L.P. 70,000$2,300,0001.58%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 89,810$2,951,0001.38%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$86,315,0001.16%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders